Clinical trial
SRS Study in Patients With Non-Small Cell Lung Cancer
NCT00489008 · M.D. Anderson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00489008 |
|---|---|
| Title | SRS Study in Patients With Non-Small Cell Lung Cancer |
| Official title | Phase II Stereotactic Body Radiotherapy for Stage I (T1-T2, N0, M0), Selective Stage II (Chest Wall T3, N0M0) or Isolated Peripheral Lung Recurrent Non-Small Cell Lung Cancer (NSCLC) |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Procedure |
| Interventions | Stereotactic Body Radiation Therapy (SBRT) |
| Enrollment | 141 |
| Start date | Nov 21, 2005 |
| Primary completion | Jun 2, 2017 |
| Completion | Jun 2, 2017 |
| First posted | Jun 21, 2007 |
| Last update posted | Mar 30, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: